Study |
Red flags |
First-order testing | |
Creatinine |
Evidence of renal impairment |
Electrolytes (potassium) |
Hypokalemia suggesting potential mineralocorticoid excess |
Midstream urine |
Evidence of proteinuria or hematuria suggesting a renal etiology |
Urine PCR or 24-h urine collection for protein |
If midstream urine is positive for proteinuria, recommend for baseline and quantitative assessment |
Second-order testinga | |
Renal ultrasonography with Doppler |
If sudden-onset or worsening hypertension, presence of abdominal bruit, resistance to ≥3 drugs, increase in serum creatinine ≥30% after using ACEI/ARB, significant asymmetry (>1.5 cm) in kidney size, recurrent pulmonary edema, significant atherosclerosis, family history of fibromuscular dysplasia, or personal history in another vascular territory |
Sleep study |
If evidence of sleep apnea in history (headache, nocturnal choking and gasping, early morning fatigue, snoring) |
Plasma renin and aldosterone |
If evidence of spontaneous hypokalemia (K <3.5 mmol/L) or hypokalemia with diuretics, resistance to ≥3 drugs, incidental adrenal adenoma |
24-h urine metanephrines |
If severe ≥180/110 mm Hg refractory hypertension, symptoms of catecholamine excess (headaches, palpitations, sweating, panic attacks, orthostatic syncope), hypertension triggered by beta-blockers, history of multiple endocrine neoplasia 2A or 2b, or incidental adrenal mass |
TSH |
If evidence of hypothyroidism or hyperthyroidism on clinical assessment |
a Only undertaken if signs and symptoms present (see Essential Hypertension). | |
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; PCR, protein-to-creatinine ratio; TSH, thyroid-stimulating hormone. |